Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Javier Ampuero Herrojo

Profesor Contratado Doctor (Plaza Vinc.)
jampuero-ibis@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Enfermedades hepáticas y digestivas - CTS-1106 (Universidad de Sevilla)
Centro mixto: Instituto de Biomedicina de Sevilla (IBIS)

Investiga en

Palabras clave
Líneas de investigación
Resumen
Tipo Año Título Fuente
Revisión2025 Brain reserve in hepatic encephalopathy: Pathways of damage and preventive strategies through lifestyle and therapeutic interventions ANNALS OF HEPATOLOGY
Corrección2025 Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Letter2025 Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF) HEPATOLOGY
Artículo2025 Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis JHEP Reports
Artículo2025 Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries. DIGESTIVE AND LIVER DISEASE
Artículo2025 Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults Transplantation Direct
Artículo2025 Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) Revista Española de Enfermedades Digestivas
Artículo2025 Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2025 Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C JOURNAL OF HEPATOLOGY
Artículo2024 Ammonia-induced stress response in liver disease progression and hepatic encephalopathy. Nature Reviews Gastroenterology and Hepatology
Artículo2024 An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) NATURE METABOLISM
Artículo2024 Biomarcadores en MASLD, ¿estamos ante una nueva era? GASTROENTEROLOGIA Y HEPATOLOGIA
Revisión2024 Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance RNA BIOLOGY
Artículo2024 Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease EUROPEAN JOURNAL OF INTERNAL MEDICINE
Artículo2024 Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2024 Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry JOURNAL OF HEPATOLOGY
Resumen congreso2024 Differential transcriptomic profile in platelet-derived extracellular vesicles in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) JOURNAL OF HEPATOLOGY
Resumen congreso2024 Dysregulation of ureagenesis and glutaminolysis in DIAMONDTM mice played a major role in MASLD progression JOURNAL OF HEPATOLOGY
Resumen congreso2024 ENTPD1/ CD39 REGULATES INFLAMMATORY PROCESS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD) HEPATOLOGY
Artículo2024 FIB-4 score as predictor of COVID-19-related severity in hospitalized patients. Revista Española de Enfermedades Digestivas
Artículo2024 Fibroblast growth factor 21 is a hepatokine involved in MASLD progression UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
Resumen congreso2024 Identification and assessment of new circulating serological biomarkers for the evaluation of liver disease severity in MASLD patients JOURNAL OF HEPATOLOGY
Artículo2024 Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Revisión2024 Novel insights into metabolic-associated steatotic liver disease preclinical models LIVER INTERNATIONAL
Artículo2024 One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
Resumen congreso2024 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation JOURNAL OF HEPATOLOGY
Resumen congreso2024 Platelet-derived extracellular vesicles (PEVs) as a potential biomarker for hepatocellular carcinoma (HCC) JOURNAL OF HEPATOLOGY
Artículo2024 Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy HEPATOLOGY
Short Survey2024 Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2024 Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry LIVER INTERNATIONAL
Artículo2024 Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease GUT
Artículo2024 Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF) HEPATOLOGY
Artículo2024 The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis Journal of Gastroenterology
Artículo2024 Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial GUT
Resumen congreso2024 Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry JOURNAL OF HEPATOLOGY
Letter2023 A second update on mapping the human genetic architecture of COVID-19 NATURE
Artículo2023 AEEH «Consensus about detection and referral of hidden prevalent liver diseases» GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2023 An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography. JOURNAL OF HEPATOLOGY
Resumen congreso2023 Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studies JOURNAL OF HEPATOLOGY
Resumen congreso2023 At- risk nash identification using an algorithm that combines fib-4+masef ( metabolomicsadvanced steatohepatitis fibrosis score) HEPATOLOGY
Resumen congreso2023 Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD) JOURNAL OF HEPATOLOGY
Artículo2023 Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis. Biomarker Research
Revisión2023 Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: From diagnosis to prognosis ANNALS OF HEPATOLOGY
Corrección2023 Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022)) JOURNAL OF HEPATOLOGY
Artículo2023 Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis JOURNAL OF HEPATOLOGY
Resumen congreso2023 Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathy JOURNAL OF HEPATOLOGY
Resumen congreso2023 EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT HEPATOLOGY
Resumen congreso2023 Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) JOURNAL OF HEPATOLOGY
Revisión2023 Enfermedad de Wilson MEDICINA CLINICA
Resumen congreso2023 First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs JOURNAL OF HEPATOLOGY
Resumen congreso2023 Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2023 HISTOLOGICAL CLASSIFICATIONS AND PREDICTION OF LIVER- RELATED EVENTS : RESULTS FROM THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY ( HOTSURFR) STUDY HEPATOLOGY
Resumen congreso2023 Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study JOURNAL OF HEPATOLOGY
Resumen congreso2023 Identification of new serological biomarkers for the detection of significant fibrosis HEPATOLOGY
Resumen congreso2023 Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Resumen congreso2023 Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry JOURNAL OF HEPATOLOGY
Artículo2023 Impacto de la enseñanza integrada de la patología médico-quirúrgica en pequeños grupos basada en la resolución de problemas en el aprendizaje de la medicina Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
Artículo2023 Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals INFLAMMATORY BOWEL DISEASES
Resumen congreso2023 Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes JOURNAL OF HEPATOLOGY
Artículo2023 Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Artículo2023 Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort Revista Española de Enfermedades Digestivas
Resumen congreso2023 Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates JOURNAL OF HEPATOLOGY
Resumen congreso2023 Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry JOURNAL OF HEPATOLOGY
Artículo2023 Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis CELL DEATH & DISEASE
Resumen congreso2023 NOVEL ARTIFICIAL INTELLIGENCE-ASSISTED DIGITAL PATHOLOGY QUANTITATIVE IMAGE ANALYSIS PREDICTS THE OCCURRENCE OF LIVER-RELATED CLINICAL EVENTS IN THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY (HOTSURFR) STUDY HEPATOLOGY
Resumen congreso2023 Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study JOURNAL OF HEPATOLOGY
Artículo2023 Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis LANCET GASTROENTEROLOGY & HEPATOLOGY
Artículo2023 Predicting liver-related events in NAFLD: A predictive model HEPATOLOGY
Resumen congreso2023 PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS) HEPATOLOGY
Editorial2023 Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant GASTROENTEROLOGY
Artículo2023 Reingresos hospitalarios en pacientes cirróticos: un desafío en el horizonte Revista Andaluza de Patología Digestiva
Resumen congreso2023 Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies JOURNAL OF HEPATOLOGY
Resumen congreso2023 Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial JOURNAL OF HEPATOLOGY
Artículo2023 Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. LIVER INTERNATIONAL
Artículo2023 Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant HEPATOLOGY COMMUNICATIONS
Resumen congreso2023 Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH JOURNAL OF HEPATOLOGY
Resumen congreso2023 The combination of LACE index, MELDon discharge and a previous history of decompensation defines risk groups for early readmission in patients with liver cirrhosis JOURNAL OF HEPATOLOGY
Revisión2023 The essential role of IL-17 as the pathogenetic link between psoriasis and metabolic-associated fatty liver disease Life
Resumen congreso2023 Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI) JOURNAL OF HEPATOLOGY
Artículo2022 A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2022 A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy CANCERS
Resumen congreso2022 Approaches for a hepatitis C-free city: preliminary results JOURNAL OF HEPATOLOGY
Artículo2022 Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool Biomarker Research
Artículo2022 Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease FRONTIERS IN MEDICINE
Artículo2022 Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? GUT
Artículo2022 Co-12. Eficacia y seguridad de las prótesis de aposición luminal en el drenaje ecoendoscópico de colecciones abdominales y la influencia del catéter pigtail coaxial en la tasa de complicaciones y de revisiones endoscópicas. Revista Andaluza de Patología Digestiva
Resumen congreso2022 Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysis JOURNAL OF HEPATOLOGY
Revisión2022 Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver Frontiers in Endocrinology
Corrección2022 Correction to: A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2022 Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis EUROPEAN JOURNAL OF INTERNAL MEDICINE
Resumen congreso2022 Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLD JOURNAL OF HEPATOLOGY
Artículo2022 Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis GUT
Resumen congreso2022 Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model JOURNAL OF HEPATOLOGY
Revisión2022 Emerging pharmacological treatment options for MAFLD Therapeutic Advances in Endocrinology and Metabolism
Resumen congreso2022 EpCAM+CD133+Microvesicles: novel biomarker in NAFLD HEPATOLOGY
Artículo2022 Extracellular Vesicles as Biomarkers in Liver Disease INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Revisión2022 General overview about the current management of nonalcoholic fatty liver disease CLINICAL DRUG INVESTIGATION
Resumen congreso2022 Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase HEPATOLOGY
Artículo2022 Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies. Journal of Clinical and Translational Hepatology
Resumen congreso2022 Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Resumen congreso2022 Impact of genes related to metabolic associated fatty liver disease (MAFLD) in response to hypocaloric dietary intervention: nutrigenomic analysis HEPATOLOGY
Artículo2022 Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function JOURNAL OF HEPATOLOGY
Artículo2022 Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation Scientific reports
Artículo2022 Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2022 Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma LIVER INTERNATIONAL
Revisión2022 Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2022 Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events JOURNAL OF HEPATOLOGY
Artículo2022 Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis JOURNAL OF HEPATOLOGY
Artículo2022 Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology LIVER INTERNATIONAL
Artículo2022 Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study NUTRICION HOSPITALARIA
Letter2022 Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes GUT
Resumen congreso2022 Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose. JOURNAL OF HEPATOLOGY
Artículo2022 Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD Journal of Gastroenterology
Artículo2021 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. JOURNAL OF CLINICAL INVESTIGATION
Artículo2021 An experimental DUAL model of advanced liver damage HEPATOLOGY COMMUNICATIONS
Revisión2021 Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases FRONTIERS IN IMMUNOLOGY
Resumen congreso2021 Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease. ATHEROSCLEROSIS
Artículo2021 Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old CLINICAL PHARMACOLOGY & THERAPEUTICS
Artículo2021 CO-03. Impacto del tratamiento antiviral con tenofovir para la hepatitis crónica b en la incidencia de infección sars-cov-2 y covid-19. Estudio multicéntrico covhb Revista Andaluza de Patología Digestiva
Artículo2021 CO-14. Evaluación de la capacidad diagnóstica de fibrosis y cuantificación de esteatosis hepática mediante rm en pacientes con esteatosis hepática metabólica (ehmet) Revista Andaluza de Patología Digestiva
Artículo2021 CO-16. Colangitis biliar primaria e infección por sars-cov-2: Incidencia, susceptibilidad y resultados Revista Andaluza de Patología Digestiva
Artículo2021 Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2021 Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry JOURNAL OF HEPATOLOGY
Letter2021 COVID-19 and the liver: the chicken or the egg dilemma Revista Española de Enfermedades Digestivas
Resumen congreso2021 Current non-invasive tests have suboptimal performance for the identification of candidates for pharmacological therapy for pre-cirrotic non-alcoholic steatohepatitis. JOURNAL OF HEPATOLOGY
Artículo2021 Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects LIVER INTERNATIONAL
Artículo2021 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection CELLULAR & MOLECULAR IMMUNOLOGY
Resumen congreso2021 Derivation and validation of the NAFLD cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis and to predict liver-related outcomes JOURNAL OF HEPATOLOGY
Artículo2021 Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2021 Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis JOURNAL OF HEPATOLOGY
Artículo2021 Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Editorial2021 Emphysematous hepatitis: a very rare entity with a poor prognosis COMMENT Revista Española de Enfermedades Digestivas
Resumen congreso2021 Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients JOURNAL OF HEPATOLOGY
Artículo2021 Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World journal of virology
Artículo2021 Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis Revista Española de Enfermedades Digestivas
Resumen congreso2021 Interim analysis from a 72 week, double-blind, placebo-controlled, multicenter, paired liver biopsy study of endoscopic sleeve gastroplasty in patients with non-alcoholic steatohepatitis (NASH) JOURNAL OF HEPATOLOGY
Artículo2021 Interrelación entre esteatosis hepática metabólica y diabetes mellitus e hipertensión arterial REVISTA DE NUTRICION PRACTICA
Resumen congreso2021 Liver related and extrahepatic events in patients with non-alcoholic fatty liver disease: a competing risk analysis JOURNAL OF HEPATOLOGY
Artículo2021 Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. JOURNAL OF HEPATOLOGY
Artículo2021 Management of NAFLD patients with advanced fibrosis LIVER INTERNATIONAL
Artículo2021 Mapping the human genetic architecture of COVID-19. NATURE
Artículo2021 Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2021 Precisión diagnóstica y limitaciones de los test no invasivos en pacientes con esteatosis hepática metabólica Revista Andaluza de Patología Digestiva
Resumen congreso2021 Prevalence estimation of significant fibrosis due to non-alcoholic steatohepatitis combining transient elastography and histology JOURNAL OF HEPATOLOGY
Editorial2021 Propuesta de nueva denominación: esteatosis hepática metabólica (EHmet) Revista Española de Enfermedades Digestivas
Letter2021 Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD” JOURNAL OF HEPATOLOGY
Artículo2021 SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome Scientific reports
Artículo2021 Simple non-invasive scoring systems and histologic scores in predicting mortality in NAFLD patients: a systematic review and meta-analysis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Letter2021 Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation Clinical and translational medicine
Revisión2021 Wilson's disease: revisiting an old friend World Journal of Hepatology
Artículo2020 Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients LIVER INTERNATIONAL
Resumen congreso2020 Circulating PCSK9 levels correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2020 Co-12. Análisis de factores que afectan la seguridad diagnóstica de la elastografía por resonancia magnética (erm) en pacientes con mafld. Revista Andaluza de Patología Digestiva
Artículo2020 Co-17. Determinación de micropartículas apoptóticas de origen hepático en pacientes con enfermedad hepática metabólica grasa Revista Andaluza de Patología Digestiva
Resumen congreso2020 Cost-effectivity analysis of several non-invasive test strategies for detection and referral of patients with non-alcoholic fatty liver disease at risk of advanced fibrosis JOURNAL OF HEPATOLOGY
Revisión2020 COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic Revista Española de Enfermedades Digestivas
Artículo2020 Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Corrección2020 Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) JOURNAL OF HEPATOLOGY
Artículo2020 Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study Clinical and translational gastroenterology
Resumen congreso2020 Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis JOURNAL OF HEPATOLOGY
Resumen congreso2020 Lack of histological steatohepatitis features in advanced fibrosis could impact in screening failure rate: a comparison with FDA clinical criteria JOURNAL OF HEPATOLOGY
Resumen congreso2020 Liver derived apoptotic microparticles as biomarkers to detect transition from simple steatosis to steatohepatitis in non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Resumen congreso2020 LncRNA-H19 as a marker of liver progression from steatosis to hepatocellular carcinoma JOURNAL OF HEPATOLOGY
Artículo2020 Manejo de la enfermedad hepática metabólica grasa Revista Andaluza de Patología Digestiva
Capítulo2020 Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider? Clinical Dilemmas in Viral Liver Disease, Second Edition
Resumen congreso2020 Non-invasive tests predict the risk of hepatocellular carcinoma in hepatitis C patients after sustained virological response: impact on HCC surveillance JOURNAL OF HEPATOLOGY
Artículo2020 Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice Polish archives of internal medicine
Artículo2020 Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy LIVER INTERNATIONAL
Editorial2020 Reflex testing. A key tool for the elimination of hepatitis C Revista Española de Enfermedades Digestivas
Resumen congreso2020 Risk factors associated to NAFLD-related advanced fibrosis in patients with normal ALT levels JOURNAL OF HEPATOLOGY
Artículo2020 Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH JOURNAL OF HEPATOLOGY
Artículo2020 Stratification of patients in NASH clinical trials: a pitfall for trial success JHEP Reports
Capítulo2020 The spectrum of NAFLD: From the organ to the system NAFLD and NASH: biomarkers in detection, diagnosis and monitoring
Artículo2019 Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria Revista Española de Enfermedades Digestivas
Artículo2019 Co-27. Índice de fibrosis hepática: Estratificación del riesgo de enfermedad hepática metabólica grasa en atención primaria. Revista Andaluza de Patología Digestiva
Resumen congreso2019 Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma HEPATOLOGY
Resumen congreso2019 Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study JOURNAL OF HEPATOLOGY
Resumen congreso2019 Epigenetic regulation of gene expression in a HCC-NASH murine model JOURNAL OF HEPATOLOGY
Resumen congreso2019 Genetic Fingerprint of Hepatic Encephalopathy Risk in Liver Cirrhosis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2019 Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD) Revista Española de Enfermedades Digestivas
Artículo2019 Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models Revista Española de Enfermedades Digestivas
Resumen congreso2019 Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2019 OXIDIZED-LDL AS A MARKER OF OXIDATIVE STRESS IS STRONGLY RELATED TO NASH IRRESPECTIVELY OF INSULIN RESISTANCE AND LIVER FIBROSIS HEPATOLOGY
Artículo2019 Quality of life in patients with hepatitis C. Importance of treatment GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2019 Sesión IV.: Búsqueda de biomarcadores en la enfermedad hepática metabólica grasa: aproximación transcriptómica Revista Andaluza de Patología Digestiva
Artículo2019 Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis JOURNAL OF HEPATOLOGY
Resumen congreso2019 The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2019 Transcriptomic and epigenetic characterization of a NAFLD murine model JOURNAL OF HEPATOLOGY
Artículo2019 Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites Revista Española de Enfermedades Digestivas
Resumen congreso2018 Burden and Variability in the Management of NAFLD Patients in Clinical Practice: Toward Unified Criteria. HEPATOLOGY
Resumen congreso2018 Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry JOURNAL OF HEPATOLOGY
Artículo2018 Co-12. Determinantes genéticos de encefalopatía hepática en pacientes con cirrosis: Análisis de genes candidatos Revista Andaluza de Patología Digestiva
Resumen congreso2018 Co-13. Disminución de micropartículas apoptóticas endoteliales y plaquetarias en pacientes con hepatitis c tras el tratamiento con aad Revista Andaluza de Patología Digestiva
Resumen congreso2018 Co-20. Mejora de la función endotelial en pacientes con virus c tras el tratamiento con aad Revista Andaluza de Patología Digestiva
Resumen congreso2018 Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica Revista Andaluza de Patología Digestiva
Artículo2018 Co-28. Carga y variabilidad en el manejo de pacientes con ehgna en la práctica clínica: Hacia criterios unificados Revista Andaluza de Patología Digestiva
Resumen congreso2018 Co-29. Investigación traslacional en ehgna: Estudio genético y funcional de fgf-21 Revista Andaluza de Patología Digestiva
Resumen congreso2018 Critical flicker frequency improves its diagnostic and predictive accuracy of hepatic encephalopathy by decreasing the dispersion between measures JOURNAL OF HEPATOLOGY
Artículo2018 Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis LIVER INTERNATIONAL
Artículo2018 Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients Therapeutic Advances in Gastroenterology
Resumen congreso2018 Dynamic of Microparticles in Patients with Hepatitis C Receiving Daa and Their Impact on Cardiovascular Risk: Hepcar Study HEPATOLOGY
Editorial2018 Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Resumen congreso2018 Effect of hepatitis C sustained virological response on the endothelial dysfunction and the cardiovascular risk. HepCAR study JOURNAL OF HEPATOLOGY
Resumen congreso2018 Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target. HEPATOLOGY
Resumen congreso2018 Genetic and functional analysis of FGF21 in NAFLD/NASH JOURNAL OF HEPATOLOGY
Resumen congreso2018 Genetic factors of hepatic encephalopathy on patients with cirrhosis: candidate gene study JOURNAL OF HEPATOLOGY
Resumen congreso2018 Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice JOURNAL OF HEPATOLOGY
Artículo2018 Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2018 Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C JOURNAL OF HEPATOLOGY
Resumen congreso2018 Incidence of HCC in TIPS bearing cirrhotic patients JOURNAL OF HEPATOLOGY
Resumen congreso2018 Metabolically Healthy Obesity Is a Dynamic Condition Which Progress to Unhealthy Status According to Nash and Fibrosis Stage in Biopsy-Proven NAFLD Patients HEPATOLOGY
Resumen congreso2018 Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity JOURNAL OF HEPATOLOGY
Artículo2018 Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy Revista Española de Enfermedades Digestivas
Artículo2018 Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Revisión2018 miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis JOURNAL OF HEPATOLOGY
Revisión2018 Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2018 Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain ANNALS OF HEPATOLOGY
Resumen congreso2018 Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma HEPATOLOGY
Artículo2018 Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy PLOS ONE
Editorial2018 Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat HEPATOLOGY
Resumen congreso2018 Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients HEPATOLOGY
Artículo2018 The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Revisión2018 The impact of minimal hepatic encephalopathy treatment in long-term prognosis Salud(i)Ciencia
Resumen congreso2017 A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasound JOURNAL OF HEPATOLOGY
Editorial2017 Acute-on-chronic liver failure: a time to step forward Revista Española de Enfermedades Digestivas
Resumen congreso2017 Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals JOURNAL OF HEPATOLOGY
Revisión2017 Cardiovascular assessment in liver transplant for nonalcoholic steatohepatitis patients: What we do, what we should do World Journal of Hepatology
Artículo2017 Co-11. La frecuencia crítica de parpadeo mejora su rendimiento diagnóstico y predictivo de encefalopatía hepática al incorporar la desviación estándar como criterio de calidad Revista Andaluza de Patología Digestiva
Artículo2017 Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional Revista Andaluza de Patología Digestiva
Artículo2017 Co-19. Estudio del perfil epigenético en una cohorte de pacientes con hepatitis crónica c: Cirróticos versus hepatocarcinoma Revista Andaluza de Patología Digestiva
Artículo2017 Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual. Revista Andaluza de Patología Digestiva
Artículo2017 Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort JOURNAL OF VIRAL HEPATITIS
Resumen congreso2017 Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice JOURNAL OF HEPATOLOGY
Artículo2017 Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort JOURNAL OF HEPATOLOGY
Artículo2017 Genetic diversity of armored scales (Hemiptera: Diaspididae) and soft scales (Hemiptera: Coccidae) in Chile Scientific reports
Resumen congreso2017 HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C JOURNAL OF HEPATOLOGY
Resumen congreso2017 Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus JOURNAL OF HEPATOLOGY
Artículo2017 Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy LIVER INTERNATIONAL
Resumen congreso2017 Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2017 Oral glutamine challenge predicts risk and defines hepatic encephalopathy types JOURNAL OF HEPATOLOGY
Artículo2017 Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2017 Time in HE in cirrhotic patients with an acute episode (>= grade 2) determines short and long-term survival JOURNAL OF HEPATOLOGY
Resumen congreso2016 Advanced fibrosis is independently associated with impaired kidney function in biopsy-proven NAFLD. Results of a multicenter cross-sectional study HEPATOLOGY
Revisión2016 Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis SEMINARS IN LIVER DISEASE
Resumen congreso2016 Charlson Comorbidity Index predicts the overall benefit of IFN-free therapy in hepatitis (HepCom Study) HEPATOLOGY
Resumen congreso2016 Critical Flicker Frequency predicts progression among stages of cirrhosis HEPATOLOGY
Resumen congreso2016 DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS JOURNAL OF HEPATOLOGY
Resumen congreso2016 EFFECTIVENESS AND SAFETY OF OMBITASVIR, PARITAPREVIR, RITONAVIR AND DASABUVIR PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C VIRUS INFECTION: RESULTS FROM THE SPANISH REALWORLD COHORT JOURNAL OF HEPATOLOGY
Resumen congreso2016 Effectiveness And Safety Of Ombitasvir, Paritaprevir/Ritonavir And Sofosfuvir/Ledipasvir In Patients With Genotype 4 Chronic Hepatitis C Virus Infection: Results From The Spanish Real World Cohort HEPATOLOGY
Resumen congreso2016 EFFECTIVENESS AND SAFETY OF SOFOSBUVIR/LEDIPASVIR TREATMENT FOR MONOINFECTED GENOTYPE 1 HCV PATIENTS IN REAL-LIFE CLINICAL PRACTICE: RESULTS FROM SPANISH HEPA-C COHORT JOURNAL OF HEPATOLOGY
Artículo2016 FibroGENE: A gene-based model for staging liver fibrosis JOURNAL OF HEPATOLOGY
Resumen congreso2016 HCV GENOTYPE 3: META-ANALYSIS WITH AVAILABLE TREATMENT OPTIONS JOURNAL OF HEPATOLOGY
Artículo2016 Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease Scientific reports
Resumen congreso2016 IMPACT OF BASAL COMORBIDITIES ON THE OVERALL BENEFIT OF DAA THERAPY IN HEPATITIS C JOURNAL OF HEPATOLOGY
Resumen congreso2016 IMPACT OF GWAS-IDENTIFIED COMMON VARIANTS ON HISTOPATHOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS JOURNAL OF HEPATOLOGY
Resumen congreso2016 Improvement of carotid intima-media thickness and ankle-brachial index in patients with hepatitis C virus after IFN-free treatment. HEPATOLOGY
Resumen congreso2016 LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis HEPATOLOGY
Artículo2016 Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2016 New technologies - new insights into the pathogenesis of hepatic encephalopathy METABOLIC BRAIN DISEASE
Resumen congreso2016 Oral glutamine challenge predicts and identifies long-term ammonia-related overt hepatic encephalopathy HEPATOLOGY
Artículo2016 Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Revisión2016 Pharmacogenetics of ribavirin-induced anemia in hepatitis C PHARMACOGENOMICS
Artículo2016 Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Revisión2016 Role of assessing liver fibrosis in management of chronic hepatitis C virus infection CLINICAL MICROBIOLOGY AND INFECTION
Resumen congreso2016 SCCA-IgM helps to identify patients at risk of long-term hepatocelullar carcinoma HEPATOLOGY
Artículo2016 Sedación endoscópica en la cirrosis hepática Revista Andaluza de Patología Digestiva
Resumen congreso2016 THE FTO RS1421085 T > C POLYMORPHISM IS ASSOCIATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER JOURNAL OF HEPATOLOGY
Ponencia2016 Validación preliminar de la aplicación Cliente/Servidor del software DeMILI para el diagnóstico de enfermedades del hígado CASEIB 2016 XXXIV Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Libro de actas
Artículo2015 2. Continuidad asistencial de la hepatitis c desde la deteccion al tratamiento: Impacto de las sesiones formativas en atencion primaria. Revista Andaluza de Patología Digestiva
Artículo2015 28. Impacto de la medición objetiva de comorbilidades en el beneficio de la terapia antiviral libre de interferón en hepatitis C Revista Andaluza de Patología Digestiva
Revisión2015 Assessing cardiovascular risk in hepatitis C: An unmet need World Journal of Hepatology
Artículo2015 Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis Revista Española de Enfermedades Digestivas
Resumen congreso2015 Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry HEPATOLOGY
Resumen congreso2015 CONTINUUM OF CARE OF HEPATITIS C FROM DETECTION TO CURE: IMPACT OF PEER-TO-PEER SESSIONS IN PRIMARY CARE JOURNAL OF HEPATOLOGY
Resumen congreso2015 CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS JOURNAL OF HEPATOLOGY
Artículo2015 Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection Genes & Immunity
Resumen congreso2015 HCV genotype 3: Meta-analysis with current options HEPATOLOGY
Artículo2015 Hepatitis C Virus Current and Evolving Treatments for Genotypes 2 and 3 GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Resumen congreso2015 Impact of comorbidities on the benefit of DAA therapy in Hepatitis C HEPATOLOGY
Resumen congreso2015 METFORMIN REDUCES HYPERAMMONEMIA IN PORTACAVAL SHUNTED RATS INHIBITING GLUTAMINASE ACTIVITY JOURNAL OF HEPATOLOGY
Artículo2015 Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis GASTROENTEROLOGY
Resumen congreso2015 PHARMACOGENOMIC STUDY TO PREDICT RIBAVIRIN AND PROTEASE-INHIBITOR-RELATED ANEMIA IN HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2015 Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study PLOS ONE
Revisión2015 Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin World Journal of Hepatology
Resumen congreso2015 ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENT JOURNAL OF HEPATOLOGY
Artículo2015 Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment JOURNAL OF CLINICAL VIROLOGY
Capítulo2015 The oral glutamine challenge in liver cirrhosis Glutamine in Clinical Nutrition
Letter2015 Trombosis portal: más allá de la cirrosis hepática GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2014 Bacterial antigen translocation in patients with cirrhosis and minimal hepatic encephalopathy is associated with increased serum ammonia and nitric oxide levels HEPATOLOGY
Editorial2014 Deciphering the Spectrum of Low-Grade Hepatic Encephalopathy in Clinical Practice GASTROENTEROLOGY
Resumen congreso2014 DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS B JOURNAL OF HEPATOLOGY
Resumen congreso2014 FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV) JOURNAL OF HEPATOLOGY
Resumen congreso2014 GLUTAMINASE GENE ALTERATION DETERMINES THE ABILITY TO PREDICT OVERT HEPATIC ENCEPHALOPATHY BOUTS BY CRITICAL FLICKER FREQUENCY AND ORAL GLUTAMINE CHALLENGE JOURNAL OF HEPATOLOGY
Revisión2014 HCV genotype 3 - the new treatment challenge ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2014 Hepatotoxicidad inducida por estanozolol Revista Andaluza de Patología Digestiva
Letter2014 Hypoxic hepatitis as diabetic ketoacidosis complication Revista Española de Enfermedades Digestivas
Resumen congreso2014 META-ANALYSIS: ROLE OF INSULIN SENSITIZERS ADDED TO PEGINTERFERON AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2014 PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C ANNALS OF HEPATOLOGY
Artículo2014 Polycystic liver in the adult (PLA) in Spain: Analysis of a structured survey analysing the experience and attitude of Spanish gastroenterologists Revista Española de Enfermedades Digestivas
Artículo2014 Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Artículo2014 Síndrome LPAC secundario a deleción del exón 4 del gen ABCB4 en un paciente con hepatitis C Revista Española de Enfermedades Digestivas
Editorial2014 Stanozolol-induced bland cholestasis GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2014 Statins and metformin use improve prognosis after diagnosis of hepatocelullar carcinoma HEPATOLOGY
Letter2014 Tetany and convulsions: Onset symptoms in crohn’s disease Revista Española de Enfermedades Digestivas
Artículo2013 Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos? GASTROENTEROLOGIA Y HEPATOLOGIA
Revisión2013 Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver WORLD JOURNAL OF GASTROENTEROLOGY
Resumen congreso2013 I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis C JOURNAL OF HEPATOLOGY
Artículo2013 Impacto de la realización de sesiones formativas en la detección de la hepatitis b y c en atención primaria (ver tabla) Revista Andaluza de Patología Digestiva
Artículo2013 Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Ponencia2013 KLF12 polymorphism improves ITPA predictability of anemia in hepatitis C treated with peginterferon plus ribavirin HEPATOLOGY
Resumen congreso2013 KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirin JOURNAL OF HEPATOLOGY
Artículo2013 Las variantes de pnpla3 promueven la esteatosis en función del genotipo viral y la ilb28 sin afectar a la respuesta viral sostenida en pacientes con hepatitis C Revista Andaluza de Patología Digestiva
Artículo2013 Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Ponencia2013 Metformin reduces plasmatic ammonia in portacaval shunted rats HEPATOLOGY
Artículo2013 Metformina reduce los niveles de amonio plástico en ratas con derivación portocava Revista Andaluza de Patología Digestiva
Letter2013 Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2013 Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk JOURNAL OF HEPATOLOGY
Artículo2013 Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables ANNALS OF HEPATOLOGY
Artículo2013 Role of diabetes mellitus on hepatic encephalopathy METABOLIC BRAIN DISEASE
Resumen congreso2013 Validation study of the impact of SNPs from GWAS associated with fibrosis progression in chronic hepatitis C (HCV) HEPATOLOGY
Artículo2012 5. Recidiva tras el cambio de la doble terapia a la monoterapia en la enfermedad de Crohn Revista Andaluza de Patología Digestiva
Ponencia2012 Anti-LDL-oxidized antibodies: a link between NASH and cardiovascular disease HEPATOLOGY
Ponencia2012 FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2012 Influencia de la enfermedad hepática por hígado graso no alcohólico sobre la enfermedad cardiovascular: Metaanálisis Revista Andaluza de Patología Digestiva
Artículo2012 Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2012 Interacción entre los genotipos virales y del hospedador influenciados por la infección del virus de la hepatitis C Revista Andaluza de Patología Digestiva
Ponencia2012 Interaction between host and viral genotypes influenced hepatitis C infection HEPATOLOGY
Ponencia2012 INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2012 Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy PLOS ONE
Ponencia2012 METFORMIN PREVENTS OVERT HEPATIC ENCEPHALOPATHY (HE) IN CIRRHOTICS: A RETROSPECTIVE OBSERVATIONAL STUDY JOURNAL OF HEPATOLOGY
Ponencia2012 METFORMIN TREATMENT REDUCES HEPATOCELLULAR CARCINOMA (HCC) RISK IN PATIENTS WITH CIRRHOSIS C: A RETROSPECTIVE OBSERVATIONAL STUDY OF TWO INDEPENDENT COHORTS JOURNAL OF HEPATOLOGY
Ponencia2012 Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis HEPATOLOGY
Artículo2012 Pancreatitis aguda e infección por Salmonella Enteritidis Revista Andaluza de Patología Digestiva
Ponencia2012 PNPLA3 and DISC1 are associated with steatosis in patients with chronic hepatitis C HEPATOLOGY
Resumen congreso2012 Predictive Factors of Erythema Nodosum and Pyoderma Gangrenosum in a Spanish Cohort of 397 Patients With Inflammatory Bowel Disease GASTROENTEROLOGY
Letter2012 Unsedated colonoscopy: an option for some but not for all GASTROINTESTINAL ENDOSCOPY
Ponencia2012 Validation of FibroMax and NAFLDscore in a cohort of NAFLD Spanish patients HEPATOLOGY
Ponencia2011 INSULIN SENSITIZER USE WAS ASSOCIATED WITH LOWER RATE OF CIRRHOSIS OUTCOMES: HEPATIC ENCEPHALOPATHY AND SPONTANEOUS BACTERIAL PERITONITIS HEPATOLOGY
Ponencia2011 NONINVASIVE ASSESSMENT OF LIVER FIBROSIS BY FORNS INDEX IS A PREDICTIVE FACTOR OF RESPONSE SIMILAR TO HISTOLOGICAL FIBROSIS IN PATIENTS WITH HEPATITIS C HEPATOLOGY
Artículo2006 Relationship between ankle-brachial index and chronic kidney disease in hypertensive patients with no known cardiovascular disease JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
DIABETES MELLITUS: IMPACT ON THE PATHOPHYSIOLOGY, DIAGNOSE AND TREATMENT OF THE HEPATIC ENCEPHALOPATHY (2015)
Dirigida por: Romero Gomez, Manuel
Tesis dirigidas/tutorizadas:5
Fecha lectura Título Rol
26/06/2023 Predictores de reingreso precoz en población con cirrosis hepática Director/a
21/02/2023 Aplicación clínica de la elastografía por resonancia magnética en la enfermedad hepática crónica Director/a
06/09/2019 GENES Y ENCEFALOPATÍA HEPÁTICA: PROPUESTA DE UNA HUELLA GENÉTICA PARA LA VALORACIÓN DEL RIESGO Director/a
12/12/2018 UTILIDAD DE LA SOBRECARGA ORAL DE GLUTAMINA EN LA PREDICCIÓN DEL RIESGO Y DEL TIPO DE ENCEFALOPATÍA HEPÁTICA Director/a
11/07/2018 EL ANTÍGENO DE CÉLULAS NEOPLÁSICAS ESCAMOSAS (SCCA) SOLO O FORMANDO EL COMPLEJO SCCA-IGM ES UN BIOMARCADOR PRECOZ DE CARCINOMA HEPATOCELULAR Director/a
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado